S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
S&P 500   3,621.63 (-0.46%)
DOW   29,638.64 (-0.91%)
QQQ   299.62 (+0.20%)
AAPL   119.05 (+2.11%)
MSFT   214.07 (-0.54%)
FB   276.97 (-0.30%)
GOOGL   1,754.40 (-1.83%)
AMZN   3,168.04 (-0.85%)
TSLA   567.60 (-3.10%)
NVDA   536.06 (+1.06%)
BABA   263.36 (-4.75%)
CGC   28.80 (-0.69%)
GE   10.18 (-2.12%)
MU   64.09 (-0.22%)
AMD   92.66 (+6.27%)
T   28.75 (-0.96%)
NIO   50.53 (-6.43%)
F   9.08 (-0.11%)
ACB   11.68 (+11.56%)
NFLX   490.70 (-0.13%)
BA   210.71 (-2.67%)
GILD   60.67 (+1.07%)
DIS   148.01 (+0.60%)
Log in
OTCMKTS:KWBT

Kiwa Bio-Tech Products Group Stock Forecast, Price & News

$0.0037
+0.00 (+5.71 %)
(As of 11/30/2020 02:59 PM ET)
Add
Compare
Today's Range
$0.00
Now: $0.00▼
$0.00
50-Day Range N/A
52-Week Range
$0.00
Now: $0.00▼
$0.07
Volume2.58 million shs
Average Volume9.85 million shs
Market Capitalization$2.01 million
P/E RatioN/A
Dividend YieldN/A
Beta3.72
Kiwa Bio-Tech Products Group Corporation, together with its subsidiaries, develops, manufactures, markets, and distributes bio-technological products for the agricultural market primarily in the People's Republic of China. It offers bacillus species and/or photosynthetic bacteria based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers. The company has a strategic cooperation agreements with the Beijing Zhongpin Agricultural Science and Technology Development Center; China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning; and Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. Kiwa Bio-Tech Products Group Corporation was founded in 2002 and is headquartered in Yangling, China.

Beat the Market (BTM) Rank™

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

0.65 out of 5 stars


Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Agricultural chemicals
Sub-IndustryN/A
SectorBasic Materials
Current SymbolOTCMKTS:KWBT
Previous Symbol
CUSIPN/A
CIK1159275
Webwww.kiwabiotech.com
Phone909-456-8828
Employees16

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$40.09 million
Price / Sales0.05
Cash FlowN/A
Price / Cash FlowN/A
Book Value$0.07 per share
Price / Book0.05

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Outstanding Shares542,717,000
Market Cap$2.01 million
Next Earnings Date12/3/2020 (Estimated)
OptionableNot Optionable
$0.0037
+0.00 (+5.71 %)
(As of 11/30/2020 02:59 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive KWBT News and Ratings via Email

Sign-up to receive the latest news and ratings for KWBT and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Kiwa Bio-Tech Products Group (OTCMKTS:KWBT) Frequently Asked Questions

How has Kiwa Bio-Tech Products Group's stock price been impacted by COVID-19 (Coronavirus)?

Kiwa Bio-Tech Products Group's stock was trading at $0.0128 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, KWBT stock has decreased by 71.1% and is now trading at $0.0037.
View which stocks have been most impacted by COVID-19.

What stocks does MarketBeat like better than Kiwa Bio-Tech Products Group?

Wall Street analysts have given Kiwa Bio-Tech Products Group a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Kiwa Bio-Tech Products Group wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Kiwa Bio-Tech Products Group's next earnings date?

Kiwa Bio-Tech Products Group is scheduled to release its next quarterly earnings announcement on Thursday, December 3rd 2020.
View our earnings forecast for Kiwa Bio-Tech Products Group.

How were Kiwa Bio-Tech Products Group's earnings last quarter?

Kiwa Bio-Tech Products Group Co. (OTCMKTS:KWBT) issued its earnings results on Tuesday, November, 20th. The company reported $0.04 earnings per share for the quarter. The business had revenue of $7.73 million for the quarter.
View Kiwa Bio-Tech Products Group's earnings history.

Who are some of Kiwa Bio-Tech Products Group's key competitors?

Some companies that are related to Kiwa Bio-Tech Products Group include Nutrien (NTR), The Scotts Miracle-Gro (SMG), The Mosaic (MOS), CF Industries (CF), ICL Group (ICL), American Vanguard (AVD), Bioceres Crop Solutions (BIOX), Bioceres Crop Solutions (BIOX), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Evogene (EVGN), Wynnstay Group Plc (WYN.L) (WYN), Eden Research plc (EDEN.L) (EDEN) and China Green Agriculture (CGA).
View all competitors.

What other stocks do shareholders of Kiwa Bio-Tech Products Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Kiwa Bio-Tech Products Group investors own include Co-Diagnostics (CODX), BioRestorative Therapies (BRTX), FuelCell Energy (FCEL), iBio (IBIO), PharmaCyte Biotech (PMCB), SANUWAVE Health (SNWV), Sierra Oncology (SRRA), Tonix Pharmaceuticals (TNXP), Aurora Cannabis Inc. (ACB.TO) (ACB) and Ascent Solar Technologies (ASTI).

Who are Kiwa Bio-Tech Products Group's key executives?

Kiwa Bio-Tech Products Group's management team includes the following people:
  • Ms. Siuhung Wang-Liu, Chairman & Corp. Sec. (Age 42, Pay $84k)
  • Mr. Hon Man Yun, Chief Financial Officer (Age 50, Pay $139.03k)
  • Mr. Xiao Qiang Yu, VP & Director (Age 42, Pay $59.93k)
  • Mr. Wade Li, Acting Pres & CEO (Age 57)
  • Dr. Yanan Tong, Chief Technology Officer
  • Prof. Qi Wang, VP of Technology & Director (Age 54)
  • Mr. Weijun Xu, C.S.O.

What is Kiwa Bio-Tech Products Group's stock symbol?

Kiwa Bio-Tech Products Group trades on the OTCMKTS under the ticker symbol "KWBT."

How do I buy shares of Kiwa Bio-Tech Products Group?

Shares of KWBT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Kiwa Bio-Tech Products Group's stock price today?

One share of KWBT stock can currently be purchased for approximately $0.00.

How big of a company is Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group has a market capitalization of $2.01 million and generates $40.09 million in revenue each year. Kiwa Bio-Tech Products Group employs 16 workers across the globe.

What is Kiwa Bio-Tech Products Group's official website?

The official website for Kiwa Bio-Tech Products Group is www.kiwabiotech.com.

How can I contact Kiwa Bio-Tech Products Group?

Kiwa Bio-Tech Products Group's mailing address is 3200 Guasti Road Suite #100, Ontario CA, 91761. The company can be reached via phone at 909-456-8828 or via email at [email protected]

This page was last updated on 11/30/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.